A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan
about
Practical implications of nanodosimetry in medicine.Antiplatelet/anticoagulant agents and chronic subdural hematoma in the elderlyCost-effectiveness of chronic kidney disease mass screening test in Japan.Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran.Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.
P2860
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A health economic evaluation o ...... ardiovascular disease in Japan
@ast
A health economic evaluation o ...... ardiovascular disease in Japan
@en
A health economic evaluation o ...... ardiovascular disease in Japan
@nl
type
label
A health economic evaluation o ...... ardiovascular disease in Japan
@ast
A health economic evaluation o ...... ardiovascular disease in Japan
@en
A health economic evaluation o ...... ardiovascular disease in Japan
@nl
prefLabel
A health economic evaluation o ...... ardiovascular disease in Japan
@ast
A health economic evaluation o ...... ardiovascular disease in Japan
@en
A health economic evaluation o ...... ardiovascular disease in Japan
@nl
P2093
P1433
P1476
A health economic evaluation o ...... ardiovascular disease in Japan
@en
P2093
Ataru Igarashi
Keita Fujikawa
Kiichiro Tsutani
Lieven Annemans
Maria Kubin
Mark Lamotte
Thomas Evers
P304
P356
10.2169/INTERNALMEDICINE.46.1843
P407
P577
2007-01-01T00:00:00Z